CHICAGO (AP) — The Chicago Bulls are missing four starters for Tuesday night's game against the Milwaukee Bucks after Joakim Noah was sidelined by a bruised right thigh.
Noah participated in the morning shootaround and coach Tom Thibodeau did not mention the injury during his pre-game availability. But the Bulls ann ...more »
WASHINGTON, USA (AP) — A biotech drug from Roche has become the first medicine approved to treat breast cancer before surgery, offering an earlier approach against one of the deadliest forms of the disease.
The Food and Drug Administration approved Perjeta for women with a form of early-stage breast cancer who face a high risk of having their cancer spread to other parts of the body.
Surgery to remove tumours is usually the first step in treating most forms of cancer. Perjeta is the first drug to be approved as a pre-surgical step.
Doctors hope that using cancer drugs earlier could help shrink tumours, making them easier to remove. In some cases, that could allow women to keep their breasts, rather than having a full mastectomy. Doctors also say that treating the disease at its earliest stages could prevent tumours from returning later, though studies have not yet established that benefit.
"By making effective therapies available to high-risk patients in the earliest disease setting, we may delay or prevent cancer recurrences," said FDA's Dr Richard Pazdur, who directs the agency's office of cancer products.
Cancer specialists already use several chemotherapy drugs as initial treatments for cancer, but they are not formally approved for the use. The FDA originally approved Perjeta to treat breast cancer that has spread to other parts of the body after surgery.
The FDA granted the drug accelerated approval for its new use based on a study showing women who received the drug as an initial treatment were more likely to be cancer-free 12 weeks later than women who received older drug combinations. Accelerated approval is reserved for drugs that show groundbreaking results for treating life-threatening diseases in early studies.
Breast cancer is highly treatable when detected early. More than 98 per cent of women who are diagnosed with first-stage breast cancer survive at least five years.
This undated file photo provided by Roche shows the initial treatment drug Perjeta. The biotech drug from Roche became the first medicine approved to treat breast cancer before surgery. (Photo: AP)
This undated file photo provided by Roche NECESSARY
shows the initial treatment drug Perjeta.
The biotech drug from Roche became the
first medicine approved to treat breast
cancer before surgery. (Photo: AP)
POST A COMMENT
1. We welcome reader comments on the top stories of the day. Some comments may be republished on the website or in the newspaper – email addresses will not be published.
2. Please understand that comments are moderated and it is not always possible to publish all that have been submitted. We will, however, try to publish comments that are representative of all received.
3. We ask that comments are civil and free of libellous or hateful material. Also please stick to the topic under discussion.
4. Please do not write in block capitals since this makes your comment hard to read.